BioCorRx raises $1M via private placement of 229,886 shares at $4.35/share to two directors

BioCorRx Inc.

Gross proceeds of $1M from sale of 229,886 shares at $4.35 per share to Lucido and Galligan trusts.
Both investors are BioCorRx board members; Louis Lucido and Joseph Galligan are the trustees.
Use of proceeds: 48% for legal fees from Buchalter; 52% for general working capital and administration.
Agreements became effective on January 12 (Lucido) and January 19 (Galligan) upon cash payment.
Shares are restricted securities issued under Rule 506 of Regulation D and bear appropriate legends.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.